INFORMAZIONI SU QUESTO EPISODIO
The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance. The top-class speakers of the series include Kay Davies (Oxford), Kevin M. Esvelt (MIT), Caroline Gutjahr (TUM), Henry T. Greely (Stanford), Dirk Inzé (Gent), Greg Newby (Broad Institute), Kai P. Purnhagen (Bayreuth), Pamela C. Ronald (UC Davis) and Jörg Vogel (HIRI/Würzburg).
The lecture series is part of the CAS Research Focus "CRISPR/Cas" . The spokesperson of this Research Focus is Prof. Dr. Eckhard Wolf (LMU).
The lecture series is part of the CAS Research Focus "CRISPR/Cas" . The spokesperson of this Research Focus is Prof. Dr. Eckhard Wolf (LMU).
Inglese
Stati Uniti
IN QUESTO EPISODIO
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di Center for Advanced Studies (CAS) Research Focus CRISPR/Cas.
ALTRI EPISODI IN QUESTO PODCAST
The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance. The top-class speakers of the series include Kay Davies (Oxford), Kevin M. Esvelt (MIT), Caroline Gutjahr (TU…
The evetn is part of the lecture series "Out of the Box: CRISPR/Cas". The lecture series reflects on the consequences of the revolutionary gene editing technology CRISPR/Cas in the fields of natural sciences and medicine, as well as its societal significance.
Genome editing gives precise control of the type of genetic modification made to a cell. Hematopoietic stem cells have pharmacologic properties of durability and output that still remain untapped. Matthew Porteus and his group are using genome editing of hematopoietic stem cells to develop new clas…
Panel discussion with Dr. Oana Dima, Prof. Dr. Caroline Gutjahr, and Prof. Dr. Kai P. Purnhagen | Moderation: Christoph von Eichhorn. The dicussion is the final event in the lecture series "Out of the Box: CRISPR/Cas".
The lecture series reflects on the consequences of the revolutionary gene editin…
Sickle cell disease is one of the most prevalent diseases worldwide. Even optimal conventional care has demonstrated inferiority compared to curative options such as hematopoietic stem cell transplantation. Gene editing promises an elegant alternative cure to all patients lacking a matched donor, p…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Center for Advanced Studies (CAS), che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
